Metastatic cancer cells with macrophage properties: Evidence from a new murine tumor model

International Journal of Cancer

Volumn 123, Issue 1, 2008, Pages 73-84

  Huysentruyt, Leanne C ^a   Mukherjee, Purna ^a   Banerjee, Dia ^a   Shelton, Laura M ^a   Seyfried, Thomas N ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

Gangliosides; Glioblastoma; Metastasis; Microglia; Neural stem cell

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GLYCOSPHINGOLIPID; PHOSPHOLIPID; PROTEIN; PROTEIN F4 80; PROTEIN IBA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BRAIN METASTASIS; CANCER CELL; CANCER INVASION; CANCER MODEL; CANCER TISSUE; CELL ADHESION; CELL INVASION; CELL STRUCTURE; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INBRED STRAIN; KIDNEY METASTASIS; LIPID COMPOSITION; LIVER METASTASIS; LUNG METASTASIS; MACROPHAGE FUNCTION; MALE; METASTASIS; MOUSE; MOUSE STRAIN; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PRIORITY JOURNAL; SPLEEN METASTASIS; TUMOR IMMUNOLOGY;

ANIMALS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL ADHESION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; KIDNEY NEOPLASMS; LIPIDS; LIVER NEOPLASMS; MACROPHAGES; MALE; MICE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHAGOCYTOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLENIC NEOPLASMS; TRANSDUCTION, GENETIC;

EID: 43949100999     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23492     Document Type: Article

References (78)

1. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-8.
2. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
3. Welch DR. Defining a cancer metastasised. AACR Education Book 2006:111-15.
4. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895-904.
5. Munzarova M, Kovarik J. Is cancer a macrophage-mediated autoaggressive disease? Lancet 1987;1:952-4.
6. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
7. Yates AJ, Thompson DK, Boesel CP, Albrightson C, Hart RW. Lipid composition of human neural tumors. J Lipid Res 1979;20:428-36.
8. Campanella R. Membrane lipids modifications in human gliomas of different degree of malignancy. J Neurosurg Sci 1992;36:11-25.
9. Sliva D, Mason R, Xiao H, English D. Enhancement of the migration of metastatic human breast cancer cells by phosphatidic acid. Biochem Biophys Res Commun 2000;268:471-9.
10. Mitsuzuka K, Handa K, Satoh M, Arai Y, Hakomori S. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem 2005;280:35545-53.
11. Morgan KT, Frith CH, Swenberg JA, McGrath JT, Zulch KJ, Crowder DM. A morphologic classification of brain tumors found in several strains of mice. J Natl Cancer Inst 1984;72:151-60.
12. Fraser H. Brain tumours in mice, with particular reference to astrocytoma. Food Chem Toxicol 1986;24:105-11.
13. El-Abbadi M, Seyfried TN, Yates AJ, Orosz C, Lee MC. Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse. Br J Cancer 2001;85:285-92.
14. Ranes MK, El-Abbadi M, Manfredi MG, Mukherjee P, Platt FM, Seyfried TN. N-butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br J Cancer 2001;84:1107-14.
15. Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer 2002;86:1615-21.
16. Drage MG, Holmes GL, Seyfried TN. Hippocampal neurons and glia in epileptic EL mice. J Neurocytol 2002;31:681-92.
17. Seyfried TN, El-Abbadi M, Roy ML. Ganglioside distribution in murine neural tumors. Mol Chem Neuropathol 1992;17:147-67.
18. Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW. Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 2004;122:131-9.
19. Oda T, Maeda H. A new simple fluorometric assay for phagocytosis. J Immunol Methods 1986;88:175-83.
20. Abate LE, Mukherjee P, Seyfried TN. Gene-linked shift in ganglioside distribution influences growth and vascularity in a mouse astrocytoma. J Neurochem 2006;98:1973-84.
21. Kasperzyk JL, d'Azzo A, Platt FM, Alroy J, Seyfried TN. Substrate reduction therapy reduces ganglioside content in postnatal cerebrum-brainstem and cerebellum in a mouse model of GM1 gangliosidosis. J Lipid Res 2005;46:744-51.
22. Macala LJ, Yu RK, Ando S. Analysis of brain lipids by high performance thin-layer chromatography and densitometry. J Lipid Res 1983;24:1243-50.
23. Yu RK, Ledeen RW. Gas-liquid chromatographic assay of lipid-bound sialic acids: measurement of gangliosides in brain of several species. J Lipid Res 1970;11:506-16.
24. Denny CA, Alroy J, Pawlyk BS, Sandberg MA, d'Azzo A, Seyfried TN. Neurochemical, morphological, and neurophysiological abnormalities in retinas of Sandhoff and GM1 gangliosidosis mice. J Neurochem 2007;101:1294-302.
25. Ecsedy JA, Yohe HC, Bergeron AJ, Seyfried TN. Tumor-infiltrating macrophages contribute to the glycosphinglipid composition of brain tumors. J Lipid Res 1998;39:2218-27.
26. Sasaki Y, Ohsawa K, Kanazawa H, Kohsaka S, Imai Y. lba1 is an actin-cross-linking protein in macrophages/microglia. Biochem Biophys Res Commun 2001;286:292-7.
27. Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci 2000;113:3073-84.
28. Guillemin GJ, Brew BJ. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004;75:388-97.
29. Eng LF. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 1985;8:203-14.
30. Trojanowski JQ, Walkenstein N, Lee VM. Expression of neurofilament subunits in neurons of the central and peripheral nervous system: an immunohistochemical study with monoclonal antibodies. J Neurosci 1986;6:650-60.
31. Yanagisawa M, Taga T, Nakamura K, Ariga T, Yu RK. Characterization of glycoconjugate antigens in mouse embryonic neural precursor cells. J Neurochem 2005;95:1311-20.
32. Seyfried TN, Yu RK. Ganglioside GD3: structure, cellular distribution, and possible function. Mol Cell Biochem 1985;68:3-10.
33. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990;60:585-95.
34. Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995;3:39-50.
35. Svennerholm L. Chromatographic separation of human brain gangliosides. J Neurochem 1963;10:613-23.
36. Khanna C, Hunter K. Modeling metastasis in vivo. Carcinogenesis 2005;26:513-23.
37. Raff MC, Mirsky R, Fields KL, Lisak RP, Dorfman SH, Silberberg DH, Gregson NA, Leibowitz S, Kennedy MC. Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature 1978;274:813-16.
38. Asou H, Hirano S, Uyemura K. Ganglioside composition of astrocytes. Cell Struct Funct 1989;14:561-8.
39. Burke B, Lewis CE. The macrophage, 2nd edn. New York: Oxford University Press, 2002.
40. Dahiya R, Boyle B, Goldberg BC, Yoon WH, Konety B, Chen K, Yen TS, Blumenfeld W, Narayan P. Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines. Biochem Cell Biol (Biochimie et biologie cellulaire). 1992;70:548-54.
41. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol 2005;288:C494-C506.
42. Lugini L, Matarrese P, Tinari A, Lozupone F, Federici C, Iessi E, Gentile M, Luciani F, Parmiani G, Rivoltini L, Malorni W, Fais S. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res 2006;66:3629-38.
43. Bai H, Seyfried TN. Influence of ganglioside GM3 and high density lipoprotein (HDL) on the cohesion of mouse brain tumor cells. J Lipid Res 1997;38:160-72.
44. Lim HK, Choi YA, Park W, Lee T, Ryu SH, Kim SY, Kim JR, Kim JH, Baek SH. Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway. J Biol Chem 2003;278:45117-27.
45. Lee HS, Park SY, Lee HW, Choi HS. Secretions of MMP-9 by soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) mediated by protein kinase C (PKC)delta and phospholipase D (PLD) in murine macrophage. J Cell Biochem 2004;92:481-90.
46. Corrotte M, Chasserot-Golaz S, Huang P, Du G, Ktistakis NT, Frohman MA, Vitale N, Bader MF, Grant NJ. Dynamics and function of phospholipase D and phosphatidic acid during phagocytosis. Traffic (Copenhagen, Denmark) 2006;7:365-77.
47. Shida D, Kitayama J, Yamaguchi H, Okaji Y, Tsuno NH, Watanabe T, Takuwa Y, Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 2003;63:1706-11.
48. Seyfried TN. Perspectives on brain tumor formation involving macrophages, glia, and neural stem cells. Perspect Biol Med 2001;44:263-82.
49. Bellingan GJ, Caldwell H, Howie SE, Dransfield I, Haslett C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol 1996;157:2577-85.
50. Munzarova M, Lauerova L, Capkova J. Are advanced malignant melanoma cells hybrids between melanocytes and macrophages? Melanoma Res 1992;2:127-9.
51. Munzarova M, Zemanova D. Transformation of blood monocytes to multinucleated giant cells in vitro: are there any differences between malignant and nonmalignant states? Physiological research/Academia Scientiarum Bohemoslovaca 1992;41:221-6.
52. Ruff MR, Pert CB. Small cell carcinoma of the lung: macrophage-specific antigens suggest hemopoietic stem cell origin. Science 1984;225:1034-6.
53. Calvo F, Martin PM, Jabrane N, De Cremoux P, Magdelenat H. Human breast cancer cells share antigens with the myeloid monocyte lineage. Br J Cancer 1987;56:15-19.
54. Ehirchiou D, Xiong Y, Xu G, Chen W, Shi Y, Zhang L. CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation. J Exp Med 2007;204:1519-24.
55. Youness E, Barlogie B, Aheam M, Trujillo JM. Tumor cell phagocytosis. Its occurrence in a patient with medulloblastoma. Arch Pathol Lab Med 1980;104:651-3.
56. Ghoneum M, Gollapudi S. Phagocytosis of candida albicans by metastatic and non metastatic human breast cancer cell lines in vitro. Cancer Detect Prev 2004;28:17-26.
57. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
58. Munzarova M, Lauerova L, Kovarik J, Rejthar A, Brezina V, Kellnerova R, Kovarik A. Fusion-induced malignancy? A preliminary study (a challenge to today's common wisdom). Neoplasma 1992;39:79-86.
59. Vignery A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int J Exp Pathol 2000;81:291-304.
60. Vignery A. Macrophage fusion: are somatic and cancer cells possible partners? Trends Cell Biol 2005;15:188-93.
61. Pawelek JM. Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 2005;6:988-93.
62. Talmadge JE, Donkor M, Scholar E. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev 2007;26:373-400.
63. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006;25:315-22.
64. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-12.
65. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-54.
66. Mallat M, Marin-Teva JL, Cheret C. Phagocytosis in the developing CNS: more than clearing the corpses. Curr Opin Neurobiol 2005;15:101-7.
67. Banaei-Bouchareb L, Peuchmaur M, Czernichow P, Polak M. A transient microenvironment loaded mainly with macrophages in the early developing human pancreas. J Endocrinol 2006;188:467-80.
68. Fan X, Salford LG, Widegren B. Glioma stem cells: evidence and limitation. Semin Cancer Biol 2007;17:214-18.
69. Pawelek JM. Tumour cell hybridization and metastasis revisited. Melanoma Res 2000;10:507-14.
70. Kaplan RN, Psaila B, Lyden D. Niche-to-niche migration of bone-marrow-derived cells. Trends Mol Med 2007;13:72-81.
71. Rubinstein LJ. Tumors of the central nervous systemed. Washington, DC: Armed Forces Institute of Pathology, 1972.
72. Taha M, Ahmad A, Wharton S, Jellinek D. Extra-cranial metastasis of glioblastoma multiforme presenting as acute parotitis. Br J Neurosurg 2005;19:348-51.
73. Hoffman HJ, Duffner PK. Extraneural metastases of central nervous system tumors. Cancer 1985;56:1778-82.
74. Wood GW, Morantz RA. Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors. J Natl Cancer Inst 1979;62:485-91.
75. Graeber MB, Scheithauer BW, Kreutzberg GW. Microglia in brain tumors. Glia 2002;40:252-9.
76. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005;353:811-22.
77. Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C, Markowitz D, Wu W, Liu C, Reisfeld RA, Xiang R. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 2006;116:2132-2141.
78. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717-27.